Tandon Mihir, Chetla Nitin, Hodges Jordan, Koul Akash, Dharia Sohil, Shah Dia, Samayamanthula Sai, Raghuwanshi Jasraj S, Sitsabeshon Arun, Oommen Nate, Alitz Curtis J
Orthopedic Surgery, Albany Medical College, Albany, USA.
Orthopedic Surgery, University of Virginia School of Medicine, Charlottesville, USA.
Cureus. 2024 Dec 29;16(12):e76592. doi: 10.7759/cureus.76592. eCollection 2024 Dec.
The treatment for osteoarthritis (OA) often requires total joint arthroplasty (TJA) when less invasive approaches fail. The annual incidence of TJA is rising. Metal-on-metal (MoM) hip and knee implants were widely used for TJA in the past, but complications have led to their decline. Many patients received MoM implants, and the complications affect many to this day. Metallosis, the accumulation of metal debris in the body, is one of the most dangerous problems associated with TJA and can cause many severe local and systemic effects including inflammation, pain, and organ dysfunction. The metal release causing metallosis is multifactorial, including wear on the articulating surfaces and trunnionosis. Key risk factors include implant design, taper topography, head size, material properties, and patient factors. Metallosis can present clinically with local pain and inflammation, and with severe systemic effects such as cardiomyopathy and neuropsychiatric symptoms. Adverse local tissue reactions and systemic cobaltism are significant concerns that necessitate early detection and intervention. Biomarkers revolving around cobalt and chromium ion levels are useful for screening and monitoring patients with signs of metallosis. This review aims to provide primary care physicians and orthopedic surgeons with a succinct, updated understanding of the mechanisms, risk factors, and clinical implications of metallosis to better manage TJA patients. Advancements in implant materials provide opportunities to enhance future patient outcomes and reduce the incidence of metallosis, thus promoting safer and more effective TJA.
当侵入性较小的治疗方法无效时,骨关节炎(OA)的治疗通常需要进行全关节置换术(TJA)。TJA的年发病率正在上升。过去,金属对金属(MoM)髋关节和膝关节植入物被广泛用于TJA,但并发症导致了它们的衰落。许多患者接受了MoM植入物,这些并发症至今仍影响着很多人。金属沉着病,即金属碎屑在体内的积累,是与TJA相关的最危险问题之一,可导致许多严重的局部和全身影响,包括炎症、疼痛和器官功能障碍。导致金属沉着病的金属释放是多因素的,包括关节表面磨损和柄部病变。关键风险因素包括植入物设计、锥度形貌、头部尺寸、材料特性和患者因素。金属沉着病在临床上可表现为局部疼痛和炎症,以及严重的全身影响,如心肌病和神经精神症状。不良的局部组织反应和全身钴中毒是需要早期检测和干预的重大问题。围绕钴和铬离子水平的生物标志物有助于筛查和监测有金属沉着病迹象的患者。本综述旨在为初级保健医生和骨科医生提供对金属沉着病的机制、风险因素和临床意义的简洁、最新的理解,以便更好地管理TJA患者。植入材料的进步为改善未来患者的治疗效果和降低金属沉着病的发病率提供了机会,从而促进更安全、更有效的TJA。